A codelivery system loaded with PDL1-siRNA and sorafenib enhances the therapeutic effect of sorafenib on hepatocellular carcinoma via TAT-poly-SS-lysine modified chitosan

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Global burden of primary liver cancer in 2020 and predictions to 2040

Harriet Rumgay, Melina Arnold, Jacques Ferlay et al. · Journal of Hepatology · 2022 · 2.1K citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma

Zhongjie Li, Hui-Qi Dai, Xiaowei Huang et al. · Acta Pharmacologica Sinica · 2020 · 308 citations · Full text

Medicine, Oncology, Pharmacology +12

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

Jennifer L. Bishop, Alexander Sio, Arkhjamil Angeles et al. · Oncotarget · 2014 · 281 citations · Full text

Life Sciences, Immunology, Oncology +17